Gaoling Medical, a Hangzhou-based developer of systemic infrared thermotherapy technology, has raised an undisclosed amount of money through a strategic financing round led by Huaxia Hengtian. The company’s technology integrates neurobiology, bioenergetics, and medical immunology, focusing on improving core body temperature to address sub-health conditions and various diseases.
Therapeutic Applications and Innovations
The decrease in core body temperature is a significant factor contributing to sub-health, reduced resistance, and the onset of various diseases. Gaoling Medical’s deep infrared thermotherapy technology is designed to effectively raise core body temperature, with potential medical applications in tumor treatment, skin disease management, anti-inflammatory and pain relief, immune system enhancement, rehabilitation physiotherapy, and the elimination of gynecological inflammation.
Gaoling Medical has innovated on the wIRA valve optical core technology, which has demonstrated positive effects in tumor adjuvant treatment, analgesia, chronic inflammation management, immune activation, depression treatment, and wound healing. The company has developed six thermotherapy products, further expanding its portfolio of medical solutions.
Future Outlook
The strategic financing round positions Gaoling Medical to accelerate the development and commercialization of its infrared thermotherapy technology. With its innovative approach and broad therapeutic applications, Gaoling Medical is poised to make a significant impact in the field of medical technology, enhancing patient outcomes and contributing to advancements in healthcare.-Fineline Info & Tech
